tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Immunocore reports Q2 EPS (20c), consensus (21c)
PremiumThe FlyImmunocore reports Q2 EPS (20c), consensus (21c)
22d ago
Immunocore Holdings’ Promising PRAME-Targeting Therapies Drive Buy Rating
Premium
Ratings
Immunocore Holdings’ Promising PRAME-Targeting Therapies Drive Buy Rating
3M ago
AMD, Block upgraded: Wall Street’s top analyst calls
Premium
The Fly
AMD, Block upgraded: Wall Street’s top analyst calls
3M ago
Immunocore price target lowered to $52 from $66 at Barclays
PremiumThe FlyImmunocore price target lowered to $52 from $66 at Barclays
4M ago
Immunocore Holdings: Strong Sales Growth and Financial Position Justify Buy Rating
Premium
Ratings
Immunocore Holdings: Strong Sales Growth and Financial Position Justify Buy Rating
4M ago
Immunocore Holdings: Strong International Growth and Promising Clinical Trials Drive Buy Recommendation
Premium
Ratings
Immunocore Holdings: Strong International Growth and Promising Clinical Trials Drive Buy Recommendation
4M ago
Positive Outlook on Immunocore Holdings’ Innovative HIV Program Justifies Buy Rating
PremiumRatingsPositive Outlook on Immunocore Holdings’ Innovative HIV Program Justifies Buy Rating
6M ago
Immunocore Holdings Reveals Promising HIV Trial Results
Premium
Company Announcements
Immunocore Holdings Reveals Promising HIV Trial Results
6M ago
Immunocore assumed with an Equal Weight at Morgan Stanley
Premium
The Fly
Immunocore assumed with an Equal Weight at Morgan Stanley
6M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100